All together, these data point out that overexpression of GPR65 in CD4+ T cells leads to promoting Th1 and Th17 cell differentiation in IBD patients, but lack of GPR65 in CD4+ T cells limits this effect. This evidence concerns the gene CD4 and inflammatory bowel disease.